Incyte | INCY - Résultat Par Action Eps


Fiscal Calendrier Actuel Consensus Précédent Date
FY2026Q3 Sep/2025 1.98 2.26 Nov/03
FY2026Q2 Jun/2026 3.09 1.99 1.57 Jul/28
FY2026Q1 Mar/2026 1.81 1.42 1.16 Apr/28
FY2025Q4 Dec/2025 1.80 1.93 1.43 Feb/10
FY2025Q3 Sep/2025 2.26 1.58 1.07 Oct/28




Eps Changement Date
Acadia Pharmaceuticals USD 0.18 0.16 2026-06
Agenus USD 1.02 1.32 2026-03
Agios Pharmaceuticals USD -1.69 0 2026-06
Alnylam Pharmaceuticals USD 1.84 0.15 2026-06
Amgen USD 6.29 1.14 2026-06
BioCryst Pharmaceuticals USD 0.3 0.87 2026-06
Biogen USD 3.6 0.03 2026-06
BioMarin Pharmaceutical USD 1.2 0.44 2026-06
Bristol-Myers Squibb USD 2.04 0.46 2026-06
Eli Lilly USD 8.38 0.17 2026-06
Exelixis USD 0.91 0.04 2026-06
Gilead Sciences USD -6.75 8.78 2026-06
Incyte USD 3.09 1.28 2026-06
Ionis Pharmaceuticals USD -0.69 0.13 2026-06
MacroGenics USD -0.58 0.36 2026-03
Merck USD -0.13 1.15 2026-06
Moderna USD -1.97 1.43 2026-06
Nektar Therapeutics USD -1.78 0.43 2026-03
Neurocrine Biosciences USD 2.85 0.91 2026-06
Novartis USD 2.41 0.42 2026-06
Novartis USD 1.99 0.45 2026-03
Pfizer USD 0.77 0.02 2026-06
PTC Therapeutics USD 0.92 0.95 2026-06
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 14.29 4.82 2026-06
Sarepta Therapeutics USD 0.64 2.52 2026-06
Ultragenyx Pharmaceutical USD -0.9 0.94 2026-06
Vertex Pharmaceuticals USD 4.73 0.26 2026-06